NUTX
Nutex Health, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$193.24
−2.25%Year over year
Reported trailing growth
- Revenue
- +6.9%
- EBITDA
- +63.3%
- EBIT
- +58.5%
- EPS
- +174.7%
- Free cash flow
- +229.4%
- Operating cash flow
- +228.7%
Forward estimates
Based on analyst estimates
- Revenue
- +7.8%
- EBITDA
- -18.6%
- EPS
- +2.4%
Three-year CAGR
- Revenue
- +58.6%
- EBITDA
- +93.4%
- EBIT
- +111.0%
- Net income
- +35.7%
- EPS
- +8.8%
- Free cash flow
- +89.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026